AAT

Advanced Aesthetic Technologies, Inc. is a rapidly growing multinational company dedicated to developing new technologies in aesthetic medicine. The company's flagship product, the Algeness® injectable implant series, is the result of over a decade of scientific and clinical research, designed to advance the field of aesthetic injections by enhancing the ability to achieve deep structural support, defined contours, and excellent clinical outcomes, ensuring long-lasting treatment effects. Algeness® is a 100% natural, biodegradable filler based on pure agarose, offering unique clinical and safety properties. AAT continues to invest in research and product development, expanding the scientific understanding of Algeness® and agarose while seeking innovative technologies to advance aesthetic medicine and enrich the company’s portfolio. Algeness® has received CE certification and registration qualifications in multiple countries, and is currently available in over 30 countries. AAT is pursuing FDA approval for registration in the United States and seeking registration in China through collaboration with Lanzhou Biological Technology Development Co., Ltd. (Lanzhou) and its parent company, China National Biotec Group Company Limited (CNBG).